MedPath

The effect of helium on the immune system ex vivo

Phase 2
Conditions
Immuun modulerend effect
Immunomodulating effects
Registration Number
NL-OMON33293
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
12
Inclusion Criteria

Non-smoking, healthy, male volunteers, aged 18-45 years, informed consent

Exclusion Criteria

Smoking, current or in the past six months
Alcohol or drug abuse
Allergic reaction to medication in past medical history
Chronic medication use that could influence the immune system
Presence of any condition that could influence the immune system

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath